TORONTO, Feb 26 (Reuters) - Toronto’s main stock index is poised to climb at the open on Thursday as oil prices rose, but quarterly bank results and falling gold prices may offset.
The S&P/TSX composite index .GSPTSE rose on Wednesday for a second straight session.
Below is some of the news that may affect the market.
Bank shares got a boost on Wednesday as Toronto-Dominion Bank (TD.TO) kicked off Canada’s bank reporting season with a smaller than expected drop in quarterly profit, a result that boosted both its stock and shares of its peers.[ID:nN25325226]
First-quarter bank results are expected to once again be a large influence on the index on Thursday with Royal Bank of Canada (RY.TO), National Bank of Canada (NA.TO) and Canadian Imperial Bank of Commerce (CM.TO) due to report quarterly results.
* See also: RBC profit falls 15 pct [ID:nN26538378]
* See also: CIBC results [ID:nWNAB7363]
* See also: UK launches toxic asset insurance for banks [ID:nLQ412152]
Oil rose above $43 a barrel after the United Arab Emirates announced deeper cuts in crude supply to Asia for April in a possible signal that OPEC will cut output further at its next meeting in March. [ID:nSIN102835]
* See also: Enerplus Resources Fund ERF_u.TO says will most likely convert to dividend-paying corporation [ID:nWNAB7250]
Gold slid in volatile trade to its lowest level in more than a week, but analysts said the fallback could encourage further buying by investors looking for a safe place to park their assets. [ID:nLQ92844]
See also: Gold miners see growth, base metals seek rebound [ID:NN25510781]
Newspaper and book publisher Torstar Corp (TSb.TO) reported a fourth-quarter loss and cut its annual dividend by half. The company also announced its chief executive officer Robert Prichard has decided to step down. [ID:nBNG429814]
Canada’s biggest publicly traded drugmaker Biovail Corp BVF.TO posted a quarterly profit helped by a large deferred income tax benefit, but revenue fell. [ID:nN26539694]
Labopharm DDS.TO reported a bigger quarterly loss, hurt mainly by legal fees from the U.S. patent enforcement of its key once-daily tramadol pain treatment. [ID:nN26537635]
* See also: Atrium ATB.TO results [ID:nWNAB7330]
* See also: Paladin Labs PLB.TO results [ID:nWNAB7331]
Brokerage Genuity cut TD Bank’s price target to C$42 from C$44, while UBS cut the target to C$53 from C$57, the day after Canada’s No. 2 bank reported a smaller-than-expected drop in quarterly profit.
Following is a summary of research actions on Canadian companies reported by Reuters. For more, please double click [RCH/CA]
* Raymond James raises FirstService (FSV.TO) price target
* Desjardins, RBC cut Sherritt (S.TO) price target
* UBS cuts Agrium AGU.TO to neutral from buy
$1=$1.25 Canadian Reporting by Ka Yan Ng, Editing by Chizu Nomiyama